nodes	percent_of_prediction	percent_of_DWPC	metapath
Astemizole—CYP2D6—endogenous depression	0.869	1	CbGaD
Astemizole—CYP2J2—Fatty acids—CYP2D6—endogenous depression	0.00592	0.0781	CbGpPWpGaD
Astemizole—CYP2J2—Xenobiotics—CYP2D6—endogenous depression	0.00471	0.062	CbGpPWpGaD
Astemizole—CYP2J2—Tryptophan metabolism—TPH1—endogenous depression	0.00399	0.0526	CbGpPWpGaD
Astemizole—CYP2J2—forebrain—endogenous depression	0.00313	0.0693	CbGeAlD
Astemizole—CYP2J2—cardiovascular system—endogenous depression	0.00265	0.0586	CbGeAlD
Astemizole—CYP2J2—pituitary gland—endogenous depression	0.00234	0.0519	CbGeAlD
Astemizole—CYP3A4—Farnesoid X Receptor  Pathway—FKBP5—endogenous depression	0.00222	0.0293	CbGpPWpGaD
Astemizole—ABCB1—Codeine and Morphine Metabolism—CYP2D6—endogenous depression	0.00213	0.0281	CbGpPWpGaD
Astemizole—Fluspirilene—HTR1A—endogenous depression	0.00207	0.214	CrCbGaD
Astemizole—CYP2J2—midbrain—endogenous depression	0.00207	0.0457	CbGeAlD
Astemizole—CYP2J2—thyroid gland—endogenous depression	0.00202	0.0447	CbGeAlD
Astemizole—CYP2J2—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.00195	0.0257	CbGpPWpGaD
Astemizole—CYP2J2—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.00193	0.0254	CbGpPWpGaD
Astemizole—CYP3A7—Xenobiotics—CYP2D6—endogenous depression	0.00188	0.0247	CbGpPWpGaD
Astemizole—CYP3A7—endocrine gland—endogenous depression	0.00181	0.0402	CbGeAlD
Astemizole—CYP2J2—endocrine gland—endogenous depression	0.00181	0.0402	CbGeAlD
Astemizole—Fluspirilene—SLC6A4—endogenous depression	0.00176	0.182	CrCbGaD
Astemizole—CYP2J2—nervous system—endogenous depression	0.0017	0.0376	CbGeAlD
Astemizole—CYP2J2—central nervous system—endogenous depression	0.00164	0.0362	CbGeAlD
Astemizole—CYP2J2—cerebellum—endogenous depression	0.0016	0.0354	CbGeAlD
Astemizole—CYP2J2—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.00158	0.0209	CbGpPWpGaD
Astemizole—Pimozide—HTR1A—endogenous depression	0.00155	0.16	CrCbGaD
Astemizole—CYP3A5—Xenobiotics—CYP2D6—endogenous depression	0.00136	0.0179	CbGpPWpGaD
Astemizole—Fluspirilene—HTR2A—endogenous depression	0.00136	0.14	CrCbGaD
Astemizole—KCNH2—forebrain—endogenous depression	0.00133	0.0295	CbGeAlD
Astemizole—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—endogenous depression	0.00131	0.0173	CbGpPWpGaD
Astemizole—CYP3A5—Tamoxifen metabolism—CYP2D6—endogenous depression	0.0013	0.0172	CbGpPWpGaD
Astemizole—CYP2J2—brain—endogenous depression	0.0013	0.0287	CbGeAlD
Astemizole—CYP2J2—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.00119	0.0157	CbGpPWpGaD
Astemizole—KCNH2—cardiovascular system—endogenous depression	0.00113	0.025	CbGeAlD
Astemizole—HRH1—Monoamine GPCRs—HTR1A—endogenous depression	0.00113	0.0148	CbGpPWpGaD
Astemizole—HRH1—Monoamine GPCRs—HTR2C—endogenous depression	0.00109	0.0143	CbGpPWpGaD
Astemizole—HRH1—forebrain—endogenous depression	0.00107	0.0237	CbGeAlD
Astemizole—Pimozide—HTR2A—endogenous depression	0.00101	0.105	CrCbGaD
Astemizole—Flunarizine—CYP2D6—endogenous depression	0.00101	0.104	CrCbGaD
Astemizole—KCNH2—pituitary gland—endogenous depression	0.000998	0.0221	CbGeAlD
Astemizole—KCNH2—SIDS Susceptibility Pathways—TPH1—endogenous depression	0.000958	0.0126	CbGpPWpGaD
Astemizole—CYP2J2—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000957	0.0126	CbGpPWpGaD
Astemizole—HRH1—Monoamine GPCRs—HTR7—endogenous depression	0.000952	0.0126	CbGpPWpGaD
Astemizole—HRH1—Amine ligand-binding receptors—HTR1A—endogenous depression	0.000946	0.0125	CbGpPWpGaD
Astemizole—Pimozide—CYP2D6—endogenous depression	0.000927	0.0958	CrCbGaD
Astemizole—HRH1—Amine ligand-binding receptors—HTR2C—endogenous depression	0.000914	0.012	CbGpPWpGaD
Astemizole—KCNH2—adrenal gland—endogenous depression	0.000892	0.0197	CbGeAlD
Astemizole—KCNH2—midbrain—endogenous depression	0.00088	0.0195	CbGeAlD
Astemizole—CYP2D6—brainstem—endogenous depression	0.000842	0.0187	CbGeAlD
Astemizole—CYP2J2—Biological oxidations—CYP2D6—endogenous depression	0.000841	0.0111	CbGpPWpGaD
Astemizole—CYP2J2—Metapathway biotransformation—CYP2D6—endogenous depression	0.00083	0.0109	CbGpPWpGaD
Astemizole—CYP2D6—forebrain—endogenous depression	0.000813	0.018	CbGeAlD
Astemizole—HRH1—Amine ligand-binding receptors—HTR7—endogenous depression	0.000801	0.0105	CbGpPWpGaD
Astemizole—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.000779	0.0103	CbGpPWpGaD
Astemizole—CYP2J2—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000776	0.0102	CbGpPWpGaD
Astemizole—KCNH2—endocrine gland—endogenous depression	0.000773	0.0171	CbGeAlD
Astemizole—CYP3A7—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.000769	0.0101	CbGpPWpGaD
Astemizole—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—endogenous depression	0.000754	0.00993	CbGpPWpGaD
Astemizole—HRH1—IL-4 Signaling Pathway—GATA3—endogenous depression	0.000733	0.00966	CbGpPWpGaD
Astemizole—KCNH2—SIDS Susceptibility Pathways—TPH2—endogenous depression	0.000726	0.00957	CbGpPWpGaD
Astemizole—KCNH2—nervous system—endogenous depression	0.000724	0.016	CbGeAlD
Astemizole—HRH1—adrenal gland—endogenous depression	0.000715	0.0158	CbGeAlD
Astemizole—KCNH2—central nervous system—endogenous depression	0.000697	0.0154	CbGeAlD
Astemizole—KCNH2—cerebellum—endogenous depression	0.000681	0.0151	CbGeAlD
Astemizole—HRH1—Monoamine GPCRs—HTR2A—endogenous depression	0.000667	0.00879	CbGpPWpGaD
Astemizole—CYP3A5—endocrine gland—endogenous depression	0.000639	0.0141	CbGeAlD
Astemizole—CYP2J2—Biological oxidations—COMT—endogenous depression	0.000638	0.0084	CbGpPWpGaD
Astemizole—CYP2J2—Biological oxidations—MAOA—endogenous depression	0.000633	0.00834	CbGpPWpGaD
Astemizole—CYP3A7—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000632	0.00832	CbGpPWpGaD
Astemizole—CYP3A4—Xenobiotics—CYP2D6—endogenous depression	0.00063	0.00831	CbGpPWpGaD
Astemizole—CYP2J2—Metapathway biotransformation—COMT—endogenous depression	0.000629	0.00829	CbGpPWpGaD
Astemizole—HRH1—endocrine gland—endogenous depression	0.00062	0.0137	CbGeAlD
Astemizole—CYP3A4—Tamoxifen metabolism—CYP2D6—endogenous depression	0.000606	0.00799	CbGpPWpGaD
Astemizole—KCNH2—SIDS Susceptibility Pathways—HTR1A—endogenous depression	0.000601	0.00792	CbGpPWpGaD
Astemizole—ABCB1—forebrain—endogenous depression	0.000585	0.013	CbGeAlD
Astemizole—KCNH2—SIDS Susceptibility Pathways—GATA3—endogenous depression	0.00058	0.00765	CbGpPWpGaD
Astemizole—KCNH2—SIDS Susceptibility Pathways—SLC6A4—endogenous depression	0.00058	0.00765	CbGpPWpGaD
Astemizole—HRH1—nervous system—endogenous depression	0.00058	0.0128	CbGeAlD
Astemizole—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.000563	0.00742	CbGpPWpGaD
Astemizole—HRH1—Amine ligand-binding receptors—HTR2A—endogenous depression	0.000561	0.00739	CbGpPWpGaD
Astemizole—HRH1—central nervous system—endogenous depression	0.000559	0.0124	CbGeAlD
Astemizole—CYP3A5—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.000556	0.00732	CbGpPWpGaD
Astemizole—KCNH2—brain—endogenous depression	0.000553	0.0123	CbGeAlD
Astemizole—ABCB1—adrenal cortex—endogenous depression	0.000542	0.012	CbGeAlD
Astemizole—CYP2D6—Melatonin metabolism and effects—MAOA—endogenous depression	0.000539	0.0071	CbGpPWpGaD
Astemizole—CYP3A4—Tryptophan metabolism—TPH1—endogenous depression	0.000534	0.00704	CbGpPWpGaD
Astemizole—CYP3A4—Estrogen metabolism—COMT—endogenous depression	0.00052	0.00685	CbGpPWpGaD
Astemizole—ABCB1—HIF-1-alpha transcription factor network—ADM—endogenous depression	0.000505	0.00666	CbGpPWpGaD
Astemizole—ABCB1—cardiovascular system—endogenous depression	0.000495	0.011	CbGeAlD
Astemizole—CYP3A4—endocrine gland—endogenous depression	0.000479	0.0106	CbGeAlD
Astemizole—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000475	0.00626	CbGpPWpGaD
Astemizole—CYP2D6—endocrine gland—endogenous depression	0.000472	0.0104	CbGeAlD
Astemizole—CYP3A5—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000456	0.00602	CbGpPWpGaD
Astemizole—KCNH2—Neuronal System—CACNB2—endogenous depression	0.000456	0.00601	CbGpPWpGaD
Astemizole—CYP3A4—nervous system—endogenous depression	0.000449	0.00993	CbGeAlD
Astemizole—HRH1—brain—endogenous depression	0.000443	0.00982	CbGeAlD
Astemizole—CYP2D6—nervous system—endogenous depression	0.000441	0.00977	CbGeAlD
Astemizole—ABCB1—pituitary gland—endogenous depression	0.000438	0.0097	CbGeAlD
Astemizole—KCNH2—SIDS Susceptibility Pathways—MAOA—endogenous depression	0.000437	0.00575	CbGpPWpGaD
Astemizole—CYP3A4—central nervous system—endogenous depression	0.000432	0.00956	CbGeAlD
Astemizole—CYP2D6—central nervous system—endogenous depression	0.000425	0.00941	CbGeAlD
Astemizole—KCNH2—SIDS Susceptibility Pathways—BDNF—endogenous depression	0.000421	0.00555	CbGpPWpGaD
Astemizole—CYP2D6—cerebellum—endogenous depression	0.000415	0.0092	CbGeAlD
Astemizole—CYP2J2—Biological oxidations—POMC—endogenous depression	0.000412	0.00543	CbGpPWpGaD
Astemizole—KCNH2—SIDS Susceptibility Pathways—IL10—endogenous depression	0.000402	0.0053	CbGpPWpGaD
Astemizole—ABCB1—adrenal gland—endogenous depression	0.000391	0.00866	CbGeAlD
Astemizole—ABCB1—midbrain—endogenous depression	0.000386	0.00855	CbGeAlD
Astemizole—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000382	0.00503	CbGpPWpGaD
Astemizole—ABCB1—thyroid gland—endogenous depression	0.000378	0.00836	CbGeAlD
Astemizole—KCNH2—SIDS Susceptibility Pathways—NR3C1—endogenous depression	0.000372	0.0049	CbGpPWpGaD
Astemizole—KCNH2—SIDS Susceptibility Pathways—HTR2A—endogenous depression	0.000356	0.00469	CbGpPWpGaD
Astemizole—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000344	0.00453	CbGpPWpGaD
Astemizole—ABCB1—endocrine gland—endogenous depression	0.000339	0.00751	CbGeAlD
Astemizole—CYP2D6—brain—endogenous depression	0.000337	0.00747	CbGeAlD
Astemizole—CYP3A7—Biological oxidations—CYP2D6—endogenous depression	0.000335	0.00442	CbGpPWpGaD
Astemizole—CYP3A7—Metapathway biotransformation—CYP2D6—endogenous depression	0.000331	0.00436	CbGpPWpGaD
Astemizole—ABCB1—nervous system—endogenous depression	0.000318	0.00703	CbGeAlD
Astemizole—CYP3A7—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000309	0.00408	CbGpPWpGaD
Astemizole—ABCB1—central nervous system—endogenous depression	0.000306	0.00677	CbGeAlD
Astemizole—ABCB1—cerebellum—endogenous depression	0.000299	0.00662	CbGeAlD
Astemizole—HRH1—G alpha (q) signalling events—OXT—endogenous depression	0.000292	0.00385	CbGpPWpGaD
Astemizole—KCNH2—Neuronal System—COMT—endogenous depression	0.000276	0.00364	CbGpPWpGaD
Astemizole—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000276	0.00364	CbGpPWpGaD
Astemizole—KCNH2—Neuronal System—MAOA—endogenous depression	0.000274	0.00361	CbGpPWpGaD
Astemizole—HRH1—G alpha (q) signalling events—HTR2C—endogenous depression	0.000271	0.00358	CbGpPWpGaD
Astemizole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.000262	0.00345	CbGpPWpGaD
Astemizole—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—endogenous depression	0.000261	0.00344	CbGpPWpGaD
Astemizole—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.000258	0.0034	CbGpPWpGaD
Astemizole—CYP3A7—Biological oxidations—COMT—endogenous depression	0.000254	0.00335	CbGpPWpGaD
Astemizole—CYP3A7—Biological oxidations—MAOA—endogenous depression	0.000252	0.00333	CbGpPWpGaD
Astemizole—CYP3A7—Metapathway biotransformation—COMT—endogenous depression	0.000251	0.0033	CbGpPWpGaD
Astemizole—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000244	0.00322	CbGpPWpGaD
Astemizole—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—endogenous depression	0.000243	0.0032	CbGpPWpGaD
Astemizole—ABCB1—brain—endogenous depression	0.000243	0.00537	CbGeAlD
Astemizole—CYP3A5—Biological oxidations—CYP2D6—endogenous depression	0.000242	0.0032	CbGpPWpGaD
Astemizole—CYP3A5—Metapathway biotransformation—CYP2D6—endogenous depression	0.000239	0.00315	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—TPH1—endogenous depression	0.000237	0.00313	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—IL10—endogenous depression	0.000236	0.00311	CbGpPWpGaD
Astemizole—CYP3A5—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000224	0.00295	CbGpPWpGaD
Astemizole—HRH1—GPCRs, Class A Rhodopsin-like—HTR1A—endogenous depression	0.000217	0.00286	CbGpPWpGaD
Astemizole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000212	0.0028	CbGpPWpGaD
Astemizole—HRH1—GPCRs, Class A Rhodopsin-like—HTR2C—endogenous depression	0.00021	0.00277	CbGpPWpGaD
Astemizole—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000196	0.00259	CbGpPWpGaD
Astemizole—HRH1—Class A/1 (Rhodopsin-like receptors)—OXT—endogenous depression	0.000193	0.00255	CbGpPWpGaD
Astemizole—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1A—endogenous depression	0.000186	0.00245	CbGpPWpGaD
Astemizole—HRH1—GPCRs, Class A Rhodopsin-like—HTR7—endogenous depression	0.000184	0.00242	CbGpPWpGaD
Astemizole—CYP3A5—Biological oxidations—COMT—endogenous depression	0.000184	0.00242	CbGpPWpGaD
Astemizole—CYP3A5—Biological oxidations—MAOA—endogenous depression	0.000182	0.0024	CbGpPWpGaD
Astemizole—CYP3A5—Metapathway biotransformation—COMT—endogenous depression	0.000181	0.00239	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—TPH2—endogenous depression	0.00018	0.00237	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—CACNB2—endogenous depression	0.00018	0.00237	CbGpPWpGaD
Astemizole—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2C—endogenous depression	0.00018	0.00237	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—DPYD—endogenous depression	0.000177	0.00233	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—ADM—endogenous depression	0.000176	0.00232	CbGpPWpGaD
Astemizole—HRH1—G alpha (q) signalling events—HTR2A—endogenous depression	0.000167	0.00219	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—CACNA1C—endogenous depression	0.000165	0.00217	CbGpPWpGaD
Astemizole—CYP3A7—Biological oxidations—POMC—endogenous depression	0.000164	0.00217	CbGpPWpGaD
Astemizole—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.00016	0.0021	CbGpPWpGaD
Astemizole—CYP2D6—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000159	0.0021	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism of lipids and lipoproteins—POMC—endogenous depression	0.000158	0.00209	CbGpPWpGaD
Astemizole—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR7—endogenous depression	0.000157	0.00208	CbGpPWpGaD
Astemizole—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—endogenous depression	0.000149	0.00196	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—OXT—endogenous depression	0.000147	0.00194	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—CRH—endogenous depression	0.000147	0.00194	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—CYP2D6—endogenous depression	0.000144	0.0019	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—HTR1A—endogenous depression	0.000142	0.00187	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—HTR2C—endogenous depression	0.000137	0.0018	CbGpPWpGaD
Astemizole—CYP2D6—Biological oxidations—COMT—endogenous depression	0.000131	0.00172	CbGpPWpGaD
Astemizole—CYP2D6—Biological oxidations—MAOA—endogenous depression	0.00013	0.00171	CbGpPWpGaD
Astemizole—CYP2D6—Metapathway biotransformation—COMT—endogenous depression	0.000129	0.0017	CbGpPWpGaD
Astemizole—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—endogenous depression	0.000129	0.0017	CbGpPWpGaD
Astemizole—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000128	0.00169	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—endogenous depression	0.000122	0.00161	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—HTR7—endogenous depression	0.00012	0.00158	CbGpPWpGaD
Astemizole—CYP3A5—Biological oxidations—POMC—endogenous depression	0.000119	0.00157	CbGpPWpGaD
Astemizole—CYP3A4—Biological oxidations—CYP2D6—endogenous depression	0.000113	0.00149	CbGpPWpGaD
Astemizole—CYP3A4—Metapathway biotransformation—CYP2D6—endogenous depression	0.000111	0.00147	CbGpPWpGaD
Astemizole—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—endogenous depression	0.00011	0.00145	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—COMT—endogenous depression	0.000109	0.00144	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—MAOA—endogenous depression	0.000108	0.00143	CbGpPWpGaD
Astemizole—CYP3A4—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000104	0.00137	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—ADM—endogenous depression	9.93e-05	0.00131	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—TPH1—endogenous depression	9.47e-05	0.00125	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—ADM—endogenous depression	9.02e-05	0.00119	CbGpPWpGaD
Astemizole—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	8.81e-05	0.00116	CbGpPWpGaD
Astemizole—CYP3A4—Biological oxidations—COMT—endogenous depression	8.54e-05	0.00113	CbGpPWpGaD
Astemizole—CYP3A4—Biological oxidations—MAOA—endogenous depression	8.48e-05	0.00112	CbGpPWpGaD
Astemizole—CYP2D6—Biological oxidations—POMC—endogenous depression	8.45e-05	0.00111	CbGpPWpGaD
Astemizole—CYP3A4—Metapathway biotransformation—COMT—endogenous depression	8.43e-05	0.00111	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—HTR2A—endogenous depression	8.4e-05	0.00111	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—CRH—endogenous depression	8.32e-05	0.0011	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—OXT—endogenous depression	8.32e-05	0.0011	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—HTR1A—endogenous depression	8.01e-05	0.00106	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—HTR2C—endogenous depression	7.74e-05	0.00102	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—CRH—endogenous depression	7.56e-05	0.000996	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—OXT—endogenous depression	7.56e-05	0.000996	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—HTR1A—endogenous depression	7.27e-05	0.000959	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—TPH2—endogenous depression	7.18e-05	0.000946	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—CACNB2—endogenous depression	7.18e-05	0.000946	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—DPYD—endogenous depression	7.06e-05	0.00093	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—POMC—endogenous depression	7.05e-05	0.000929	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—HTR2C—endogenous depression	7.03e-05	0.000926	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—TPH1—endogenous depression	6.84e-05	0.000902	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—HTR7—endogenous depression	6.78e-05	0.000893	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—POMC—endogenous depression	6.71e-05	0.000884	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—CACNA1C—endogenous depression	6.56e-05	0.000865	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—HTR7—endogenous depression	6.15e-05	0.000811	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—WASF2—endogenous depression	5.82e-05	0.000768	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—CYP2D6—endogenous depression	5.74e-05	0.000756	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—WASF1—endogenous depression	5.58e-05	0.000736	CbGpPWpGaD
Astemizole—CYP3A4—Biological oxidations—POMC—endogenous depression	5.52e-05	0.000728	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—ADM—endogenous depression	5.33e-05	0.000702	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—TPH2—endogenous depression	5.19e-05	0.000684	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—CACNB2—endogenous depression	5.19e-05	0.000684	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—TPH1—endogenous depression	5.16e-05	0.000681	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—DPYD—endogenous depression	5.1e-05	0.000673	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—TPH1—endogenous depression	4.87e-05	0.000641	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—HTR2A—endogenous depression	4.75e-05	0.000625	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—CACNA1C—endogenous depression	4.74e-05	0.000625	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CRH—endogenous depression	4.46e-05	0.000588	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—OXT—endogenous depression	4.46e-05	0.000588	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—COMT—endogenous depression	4.35e-05	0.000573	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—MAOA—endogenous depression	4.32e-05	0.000569	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—HTR2A—endogenous depression	4.31e-05	0.000568	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—HTR1A—endogenous depression	4.3e-05	0.000566	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—HTR2C—endogenous depression	4.15e-05	0.000547	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—CYP2D6—endogenous depression	4.15e-05	0.000547	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—TPH2—endogenous depression	3.91e-05	0.000516	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—CACNB2—endogenous depression	3.91e-05	0.000516	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—DPYD—endogenous depression	3.85e-05	0.000507	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—POMC—endogenous depression	3.79e-05	0.0005	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—CACNB2—endogenous depression	3.69e-05	0.000486	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—TPH2—endogenous depression	3.69e-05	0.000486	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—HTR7—endogenous depression	3.63e-05	0.000479	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—DPYD—endogenous depression	3.63e-05	0.000478	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—CACNA1C—endogenous depression	3.58e-05	0.000472	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—POMC—endogenous depression	3.44e-05	0.000454	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—CACNA1C—endogenous depression	3.37e-05	0.000445	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—TPH1—endogenous depression	3.18e-05	0.000419	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—COMT—endogenous depression	3.14e-05	0.000414	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—CYP2D6—endogenous depression	3.13e-05	0.000412	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—MAOA—endogenous depression	3.12e-05	0.000411	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—POMC—endogenous depression	2.81e-05	0.00037	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—HTR2A—endogenous depression	2.55e-05	0.000336	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—CACNB2—endogenous depression	2.41e-05	0.000318	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—TPH2—endogenous depression	2.41e-05	0.000318	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—DPYD—endogenous depression	2.37e-05	0.000313	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—COMT—endogenous depression	2.37e-05	0.000313	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—MAOA—endogenous depression	2.35e-05	0.00031	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—COMT—endogenous depression	2.23e-05	0.000295	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—MAOA—endogenous depression	2.22e-05	0.000292	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—CACNA1C—endogenous depression	2.21e-05	0.000291	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—POMC—endogenous depression	2.03e-05	0.000268	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—POMC—endogenous depression	2.03e-05	0.000268	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—CYP2D6—endogenous depression	1.93e-05	0.000254	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—POMC—endogenous depression	1.53e-05	0.000202	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—COMT—endogenous depression	1.46e-05	0.000193	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—MAOA—endogenous depression	1.45e-05	0.000191	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—POMC—endogenous depression	1.44e-05	0.00019	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—POMC—endogenous depression	9.45e-06	0.000124	CbGpPWpGaD
